DANIEL F HAYES, MD
Osteopathic Medicine in Ann Arbor, MI
License number
Michigan 4301078842
Category
Osteopathic Medicine
Type
Internal Medicine
License number
Michigan 4301078842
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
1500 Floor Cancer & Geriatrics Ctr, Ann Arbor, MI 48109
Phone
(734) 936-6000
(734) 936-2047
(734) 936-2047
Personal information
See more information about DANIEL F HAYES at radaris.comName
Address
Phone
505 Hughes, Charlotte, MI 48813
4840 Anson St, Lansing, MI 48911
4844 Potter Rd, Bear Lake, MI 49614
5855 Ambassador Dr, Saginaw, MI 48603
555 Scottshill, Milford, MI 48381
Professional information
Dr. Daniel F Hayes, Ann Arbor MI - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
Univers Of Mich Comp Canc Ctr
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-8901 (Phone)
1500 E Medical Center Dr, Ann Arbor 48109
(734) 647-8901 (Phone)
Certifications:
Internal Medicine, 1982, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Univers Of Mich Comp Canc Ctr
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
1500 E Medical Center Dr, Ann Arbor 48109
University of Michigan Health System
1500 East Medical Center Dr SPC 5474, Ann Arbor 48109
Education:
Medical School
Indiana University / School of Medicine
Graduated: 1979
U Tex Hlth Sci Ctr/Sw Med S
Dana Farber Cancer Inst
Indiana University / School of Medicine
Graduated: 1979
U Tex Hlth Sci Ctr/Sw Med S
Dana Farber Cancer Inst
Method For Predicting Progression Free And Overall Survival At Each Follow-Up Time Point During Therapy Of Metastatic Breast Cancer Patients Using Circulating Tumor Cells
US Patent:
2009006, Mar 5, 2009
Filed:
Aug 30, 2007
Appl. No.:
11/897504
Inventors:
William J. Allard - Harleysville PA, US
Gerald V. Doyle - Radnor PA, US
Daniel F. Hayes - Ann Arbor MI, US
Michael Craig Miller - Quakertown PA, US
Leon W.M.M Terstappen - Huntington Valley PA, US
Gerald V. Doyle - Radnor PA, US
Daniel F. Hayes - Ann Arbor MI, US
Michael Craig Miller - Quakertown PA, US
Leon W.M.M Terstappen - Huntington Valley PA, US
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
A cancer test having prognostic utility in predicting time to disease progression, overall survival, and response to therapy in patients with MBC based upon the presence and number of CTC's. The Cell Spotter® System is used to enumerate CTC's in blood. The system immunomagnetically concentrates epithelial cells, fluorescently labels the cells and identifies and quantifies CTC's. The absolute number of CTC's detected in the peripheral blood tumor load is, in part, a factor in prediction of survival, time to progression, and response to therapy. The mean time to survival of patients depended upon a threshold number of 5 CTC's per 7.5 ml of blood. Detection of CTC's in metastatic cancer represents a novel prognostic factor in patients with metastatic cancers, suggests a biological role for the presence of tumor cells in the blood, and indicates that the detection of CTC's could be considered an appropriate surrogate marker for prospective therapeutic clinical trials.
Diagnosis And Treatment Of Breast Cancer
US Patent:
2012000, Jan 12, 2012
Filed:
Jul 7, 2011
Appl. No.:
13/178128
Inventors:
Daniel Hayes - Ann Arbor MI, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C12Q 1/68, G01N 33/577, G01N 33/566, C12Q 1/02
US Classification:
435 612, 435 29, 435 723
Abstract:
The present invention relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present invention relates to compositions and methods for the prediction of a subject's response to cancer therapies.
Daniel F Hayes, Ann Arbor MI
Specialties:
Oncologist
Address:
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Indiana University, School of Medicine - Doctor of Medicine
Dana-Farber Cancer Institute - Fellowship - Oncology (Internal Medicine)
Dana-Farber Cancer Institute - Fellowship - Oncology (Internal Medicine)
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine, American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Daniel Fleming Hayes, Ann Arbor MI
Specialties:
Internal Medicine, Medical Oncology, Hematology & Oncology
Work:
University of Michigan CCC, 6312 Cc
1500 E Medical Center Dr, Ann Arbor, MI 48109
1500 E Medical Center Dr, Ann Arbor, MI 48109
Education:
Indiana University(1979)
Circulating Tumor Cell Capturing Techniques And Devices
US Patent:
2013030, Nov 21, 2013
Filed:
Jan 31, 2013
Appl. No.:
13/756121
Inventors:
Daniel F. Hayes - Ann Arbor MI, US
International Classification:
G01N 1/34
US Classification:
435 29, 4352871, 4352887
Abstract:
Candidate cells, such as circulating tumor cells (CTCs), present with blood are captured using a multiple stage device, having successive stages configured to deviate candidate cells out of the blood while slowing down the flow rates of the deviated resultant for easier capture of CTCs through progressive stages. The devices can include separation channel and deviation channels formed of micro-post patterns dimensioned to deviate different desired candidate cells for analysis.